CD8A and neoplasm: To evaluate the systemic immunologic effects of cell-based immunotherapy (GVAX) in either non-transgenic or tumor-bearing ProHA × TRAMP mice, we adoptively transferred CFSE-labeled, HA-specific CD8 T cells.